v3.23.3

Significant Transactions (Summary of Asset Acquisition) (Details) - USD ($) | Sep. 19, 2022 | Aug. 23, 2021
--- | --- | ---
Purchase price allocated |  | $ 7,500,000
RubrYc Therapeutics, Inc. [Member] |  |
Purchase price allocated | $ 1,342,000 |
Series A-2 Preferred Stock [Member] |  |
Purchase price allocated |  | 1,760,000
Asset Acquisition Intangible Assets [Member] |  |
Purchase price allocated |  | 4,300,000
Asset Acquisition Intangible Assets [Member] | RubrYc Therapeutics, Inc. [Member] |  |
Purchase price allocated | 1,228,000 |
Asset Acquisition Fixed Assets [Member] | RubrYc Therapeutics, Inc. [Member] |  |
Purchase price allocated | $ 114,000 |
Asset Acquisition Prepaid Expenses [Member] |  |
Purchase price allocated |  | $ 1,440,000

X
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 30 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2 + Details
Name: | us-gaap_AssetAcquisitionConsiderationTransferred
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_CounterpartyNameAxis=ibio_RubrycTheraputicsInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=ibio_Series2PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=ibio_AssetAcquisitionIntangibleAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=ibio_AssetAcquisitionFixedAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AssetAcquisitionAxis=ibio_AssetAcquisitionPrepaidExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |